BCQ

BCQ

Vital Nutrients4.6 (813 ratings)
Format:Capsule Quantity: 240 Capsule(s) · 80 servings
Goals
$102.90 $1.28 per serving

Product analysis

49 out of 100

BCQ combines turmeric and boswellia for possible joint comfort support, although benefits depend on the particular extracts used. Its relatively high ingredient costs weaken its value.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality33

Turmeric and boswellia have named components, while bromelain and quercetin leave their preparations unspecified. Those details are insufficient to establish that the ingredients match preparations with demonstrated benefits.

Ingredient Transparency65

All four ingredient amounts are listed. Missing preparation details and mixture proportions limit a fuller comparison.

Value For Money26

Turmeric and bromelain compare poorly on cost. Boswellia and quercetin lack enough information for a dependable value judgment.

Customer Satisfaction77

Customer feedback is generally favorable. Several hundred reviews provide useful context, though they cannot establish the joint benefits.

Product Focus61

Joint comfort and inflammation-related support give the formula a reasonably focused purpose. Expected benefits remain modest and uncertain because the preparations differ from those with the clearest evidence.

Format
Capsule
Container
240 Capsule(s)
Per serving
$1.28
Customer rating
4.6 · 813 ratings
Report analysis

Goals

Impact
Moderate effect
B Ingredient FitF PathwaysD- EvidenceA Formulation Logic
Boswellia · 600 mg
Study evidence
Boswellia Supportive 19 studies
Bromelain Supportive 12 studies
Joint Health
Impact
Moderate effect
B- Ingredient FitD PathwaysD- EvidenceA+ Formulation Logic
Boswellia · 600 mg
Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per servingScore
Boswellia serrata gum extract (Alpha Boswellic Acid, Beta Boswellic Acid)
600 mg 30
Bromelain
300 mg 43
Curcuma longa rhizome extract (Total Curcuminoids)
600 mg 6
Quercetin Dihydrate
300 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
Bromelain · 300 mg OverallScore43
F Composition And Label DisclosureC Composition And Label DisclosureF Commercial Price And Usability
The labeled serving provides 300 mg of bromelain, with a high whole-product cost per 500 mg. GDU or MCU activity is unavailable. The botanical source is not specified in the available information.
How this ingredient is rated

Composition and Label Disclosure36

Bromelain mass is given, but GDU or MCU activity is unavailable. A specific GDU per gram concentration is unavailable.
Enzyme Activity Disclosure
Bromelain mass is given, but GDU or MCU activity is unavailable.
Declared GDU per Gram
A specific GDU per gram concentration is unavailable.

Composition and Label Disclosure60

The labeled serving contains 300 mg of bromelain. The botanical source is not specified in the available information.
Declared Bromelain Mass
The labeled serving contains 300 mg of bromelain.
Botanical Source Disclosure
The botanical source is not specified in the available information.

Commercial Price and Usability20

The whole-product cost per 500 mg of declared bromelain is high.
Cost per 500 mg Declared Bromelain
The whole-product cost per 500 mg of declared bromelain is high.
F Composition And Label DisclosureC Composition And Label Disclosure
A serving lists 600 mg of Boswellia serrata gum extract, but the boswellic acid percentage is unknown. The available price covers the whole product serving, so it does not establish the cost of boswellia alone.
How this ingredient is rated

Composition and Label Disclosure0

The boswellic acid percentage is unknown.
Marker and Preparation Disclosure
The boswellic acid percentage is unknown.

Composition and Label Disclosure60

The boswellia amount is stated, but its boswellic acid percentage is not available.
Boswellia Amount and Marker Disclosure
The boswellia amount is stated, but its boswellic acid percentage is not available.

Commercial Price and Usability

Value was not assessed for boswellia.
F Composition And Label DisclosureF Composition And Label DisclosureF Commercial Price And Usability
A serving provides 600 mg turmeric rhizome extract at a relatively high cost. Its curcuminoid content is unknown.
How this ingredient is rated

Composition and Label Disclosure10

The rhizome extract has no stated curcuminoid concentration.
Declared Total Curcuminoid Concentration
The rhizome extract has no stated curcuminoid concentration.

Composition and Label Disclosure0

The curcuminoid amount is unknown.
Preparation and Marker Amount Disclosure
The curcuminoid amount is unknown.

Commercial Price and Usability10

The cost per serving is relatively high.
Selected-Serving Price Comparison
The cost per serving is relatively high.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsInflammation forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsInflammation forBoswellia
  3. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsInflammation forBoswellia
  4. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsInflammation Joint Health forBoswellia
  5. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsInflammation Joint Health forBoswellia
  6. Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
    Ordesi P; Pisoni L; Nannei P; Macchi M; Borloni R; Siervo S · Quintessence international (Berlin, Germany : 1985) · 2016
    Randomized trial80 participantsInflammation forBromelain
  7. Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
    Mendes ML; do Nascimento-Júnior EM; Reinheimer DM; Martins-Filho PR · Medicina oral, patologia oral y cirugia bucal · 2019
    Meta-analysis6 studies pooledInflammation forBromelain
  8. Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.
    Müller S; März R; Schmolz M; Drewelow B; Eschmann K; Meiser P · Phytotherapy research : PTR · 2013
    Randomized trial12 participantsInflammation forBromelain
  9. An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study.
    Colletti A; Procchio C; Pisano M; Martelli A; Pellizzato M; Cravotto G · Nutrients · 2024
    Randomized trial42 participantsInflammation forBromelain
  10. Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.
    Muhammad ZA; Ahmad T · JPMA. The Journal of the Pakistan Medical Association · 2019
    Narrative reviewInflammation forBromelain
  11. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  12. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  13. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia
  14. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies.
    Brien S; Lewith G; Walker A; Hicks SM; Middleton D · Evidence-based complementary and alternative medicine : eCAM · 2024
    Narrative reviewJoint Health forBromelain
  15. Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis.
    Kasemsuk T; Saengpetch N; Sibmooh N; Unchern S · Clinical rheumatology · 2017
    Randomized trial40 participantsJoint Health forBromelain
  16. Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.
    Henrotin Y; Pap T; Lieten S; Badot V; Dubuc JE; Urbin-Choffray D; von Eynatten M; Johansen OE; Rau S; Brabants K · RMD open · 2025
    Randomized trial45 participantsJoint Health forBromelain
  17. Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials
    Ueberall MA, Mueller-Schwefe GH, Wigand R, Essner U · Journal of Pain Research · 2016
    Meta-analysis697 participants6 studies pooledJoint Health forBromelain
  18. The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial
    Bolten WW, Glade MJ, Raum S, Ritz BW · Arthritis · 2015
    Randomized trial150 participantsJoint Health forBromelain